Need all Congresses? Press Enter for expanded federal results.

HB 466

Delaware House bill in Session 153.

Status: introduced. Latest action: June 4, 2026.

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE APPLICATION OF NASAL EPINEPHRINE.

Bill ID DE-153-HB-466
Session 153
Status introduced
Committee Health & Human Development
House introduced 2026-06-04
Summary

This Act adds authority and guidelines for access to and use of intranasal epinephrine nasal sprays at institutions of higher education to the existing framework for access to and use of epinephrine injectors. This Act also removes the requirement of the Department of Public Health from filing an annual report regarding the use of epinephrine autoinjectors for the prior academic year with the General Assembly under this section.

Sponsor
Neal
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-06-04 Introduced Bill introduced
2026-06-04 Status introduced
2026-06-04 Latest Action Introduced and Assigned to Health & Human Development Committee in House
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States